Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
23.99 USD | -1.60% | -2.72% | +25.34% |
May. 13 | Piper Sandler Adjusts Price Target on Myriad Genetics to $28 From $23, Maintains Neutral Rating | MT |
May. 08 | Sector Update: Health Care Stocks Softer Late Afternoon | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+25.34% | 2.21B | |
-6.16% | 12.1B | |
-3.26% | 8.16B | |
+6.61% | 5.78B | |
+31.20% | 5.59B | |
-9.05% | 4.23B | |
-56.99% | 2.87B | |
+11.87% | 2.71B | |
-5.34% | 2.35B | |
-4.87% | 1.87B |
- Stock Market
- Equities
- MYGN Stock
- News Myriad Genetics, Inc.
- Transcript : Myriad Genetics, Inc., Q1 2024 Earnings Call, May 07, 2024